出处
《中国药房》
CAS
CSCD
北大核心
2008年第7期548-550,共3页
China Pharmacy
基金
广东省科技计划项目(2005B30101008)
参考文献18
-
1Han IK, Kim MY, Byun HM, et al. Enhanced brain targeting efficiency of intranasally administered plasmid DNA. an alternative route for brain gene therapy [J ] .J Mol Med ,2007,85(1) ;75.
-
2Lambert DM. Rationale and applications of lipids as prodrug carriers[J ] .Eur J Pharm Sci, 2000, 11(2) :S15.
-
3Bodor N, Buchwald P. Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery system[J ] .Adv Drug Del Rev , 1999,36(2-3) :229.
-
4Kim HR, Gil S, Andrieux K, et al. Low- density lipoprotein receptor - mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells[J] . Cell Mol Life Sci ,2007,64(3) :356.
-
5Madhankumar AB, Slagle Interleukin - 13 receptor Webb B, Mintz A, et al. targeted nanovesicles are a potential therapy for glioblastoma multiforme[J] .Mol Cancer Ther, 2006, 5(12) : 3162.
-
6Goti D, Hrzenjak A, Levak- Frank S, et al. Porcine scavenger reeptor class B, type I is expressed at the blood- brain barrier and contributes to selective uptake of HDL - associated vitamin E[J ] .J Neuro Chem, 2001, 76(2) : 498.
-
7Mardones P, Strobel P, Miranda S, et al. Alpha - to- copherol metabolism is abnormal in scavenger receptor class B type I (SR- BI) -deficient mice[J] .J Nutr, 2002,132: 443.
-
8Tiwari SB, Amiji MM. A review of nanocarrier- based CNS delivery systems[J ] . Curt Drug Deliv, 2006, 3(2):219.
-
9Fenart L, Casanova A, Dehouck B, et al. Evaluation of effect of charge and lipid coating on ability of 60- nm nanoparticles to cross an in vitro model of the blood - brain barrier[J ] .J Pharmacol Exp Ther , 1999, 291(3) ; 1 017.
-
10Springer CJ, Niculescu - Duvaz I. Patent property of prodrug involving gene therapy ( 1996- 1999) [J ] .Exp Opin Ther Patents, 1999,9(10) : 1381.
同被引文献4
-
1张保臣.钙离子拮抗剂在颅脑损伤中的应用[J].实用医技杂志,2005,12(12A):3435-3435. 被引量：3
-
2李双利,李艳,李汝泓.尼卡地平(Nicar)在体外循环中对心和脑的作用[J].承德医学院学报,2006,23(3):294-296. 被引量：1
-
3Fujiwara K, Mikawa S, Ebina T.Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage[J].No Shinkei Geka, 2001,29( 1 ) : 23.
-
4吕超红,李素玲.尼卡地平注射液治疗蛛网膜下腔出血疗效观察[J].医药论坛杂志,2003,24(24):41-41. 被引量：1
-
1余辉.亚低温治疗重型颅脑损伤18例护理体会[J].中国乡村医药,2009,16(11):68-69.
-
2田晋嗣.神经外科住院患者静脉用药安全管理[J].中医药管理杂志,2011,19(3):271-272. 被引量：4
-
3王军,胡毅平.P-糖蛋白与阿片类药物镇痛的研究进展[J].国外医学（麻醉学与复苏分册）,2003,24(6):377-379.
-
4郭振勇,赵伟杰,刘菲.炎症和高渗溶液对莫西沙星透过血-脑脊液屏障影响的研究及疗效评价[J].中国医院用药评价与分析,2010,10(9):822-823. 被引量：7
-
5李晶,李亚珍,杨雪芹.口服给药的整体护理[J].中国实用医药,2008,3(36):209-210.
-
6许永刚,黄亮,张罡.钙拮抗剂对大鼠脑缺血后血-脑脊液屏障通透性的影响[J].临床和实验医学杂志,2017,16(2):112-114. 被引量：1
-
7马彩红,王秋红,彭永华,郑利娜.如何降低中心静脉置管的常见风险[J].现代保健（医学创新研究）,2008,5(16):149-150. 被引量：1
-
8许润春,陈晓燕,张海燕,卢燕香,杨明.脑靶向性鼻腔给药制剂的体内外评价综述[J].医学信息（中旬刊）,2010,5(10):3060-3061. 被引量：1
-
9何展文,罗向阳,李文益.血-脑脊液屏障与癫痫的研究进展[J].中华妇幼临床医学杂志（电子版）,2009,5(3):75-77.
-
10姜赞英.多途径中医给药治疗在腹膜透析患者肠梗阻中的应用[J].中国肛肠病杂志,2013(1):70-70.
